SEER Q3 2025 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+4.5% YoY

Gross Profit

$2M51.2% margin

Operating Income

-$19M-469.4% margin

Net Income

-$18M-442.5% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$309M

Total Liabilities

$37M

Stockholders' Equity

$272M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+4.5%
Gross Profit	$2M	$2M	+14.2%
Operating Income	-$19M	-$24M	+20.5%
Net Income	-$18M	-$21M	+14.5%